AN2 Therapeutics, Inc. (ANTX) Earnings
|
Expand Research on ANTX
| Next EPS Date | 8/6/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -16.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$0.23 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/11/26 |
Q126 | -$0.29 | -$0.23 | -$0.06 | N/A | N/A | N/A |  | | Details | |
| 3/17/26 |
Q425 | -$0.29 | -$0.22 | -$0.07 | N/A | N/A | N/A | | | Details | |
| 11/11/25 |
Q325 | N/A | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | N/A | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/25 |
Q225 | -$0.21 | -$0.31 | +$0.10 | N/A | N/A | N/A | | | Details |
